GGrantIndex
Sort

261,768 grants matching gene therapy

Early neonatal treatment and immune quiescence

$925,357
Louise Kuhn · Columbia University Health Sciences · U01 · FY2016 · HD

Cell Adhesion and Trafficking as a Therapeutic Target in Allotransplantation

$925,328
Allan D. Kirk · Emory University · U19 · FY2014 · AI

Dialogue between genomic instability and metabolism in diseases

$925,275
Sossou Weyemi · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Assessment, Therapy and Prevention Of Autoimmune Disease

$925,251
Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES

Signaling via MHC: engineering immune cells with new capabilities

$925,233
Alok Joglekar · University Of Pittsburgh At Pittsburgh · DP2 · FY2025 · AI

NHP MHC COMPLEX ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT - HIV/AIDS

$925,074
Daniel Geraghty · Fred Hutchinson Cancer Research Center · N01 · FY2017 · AI

Molecular pathogenesis and therapy innovation for Merkel cell carcinoma

$925,055
Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR

Regulation of Hormone Receptors and Gonadal Genes

$925,039
Maria Dufau Catt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

CureGN-Penn PCC

$925,000
Lawrence B. Holzman · University Of Pennsylvania · U01 · FY2024 · DK

Metabolic Influences on Complex Tumor Neighborhoods

$925,000
M. Celeste Simon · University Of Pennsylvania · R35 · FY2023 · CA

CUREGN 3.0 - Pediatric Nephrology Consortium - PCC

$925,000
William E. Smoyer · Research Inst Nationwide Children'S Hosp · U01 · FY2024 · DK

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network

$924,999
Andrew Stephen Bomback · Columbia University Health Sciences · U01 · FY2024 · DK

CureGN-3: UNCPCC

$924,999
Ronald J Falk · Univ Of North Carolina Chapel Hill · U01 · FY2024 · DK

NHLBI GTRP Preclinical Vector Production Core Laboratory

$924,969
James M Wilson · University Of Pennsylvania · N01 · FY2009 · HL

Development of a TRAIL-based therapy for alcohol related chronic pancreatitis

$924,849
Victor V Roschke · Theraly Fibrosis, Inc. · U44 · FY2017 · AA

The rhesus macaque as a preclinical model for induced pluripotent stem cells

$924,798
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Integrative Biology of Childhood Kidney Disease

$924,771
Ellis David Avner · Medical College Of Wisconsin · P50 · FY2008 · DK

Integrative Biology of Childhood Kidney Disease

$924,771
Ellis David Avner · Medical College Of Wisconsin · P50 · FY2009 · DK

Integrative Biology of Childhood Kidney Disease

$924,771
Ellis David Avner · Medical College Of Wisconsin · P50 · FY2011 · DK

Cancer Deep Phenotype Extraction from Electronic Medical Records

$924,689
Guergana K. Savova · Boston Children'S Hospital · U24 · FY2020 · CA

Mesothelin-targeted immunotoxins in Pancreatic Cancer

$924,682
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Integrating tumor and stroma to understand and predict treatment response

$924,643
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · U01 · FY2023 · CA

Targeting Mutant KRAS for Cancer Therapy

$924,613
Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2017 · CA

Transformative research on somatic gene recombination in the normal and Alzheimer's disease-related dementia brain

$924,514
Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG

Transformative research on somatic gene recombination in the normal and Alzheimer's disease-related dementia brain

$924,514
Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AG